CFGS
CVS icon

Concourse Financial Group Securities’s CVS Health CVS Stock Holding History

Concourse Financial Group Securities’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,553
Closed -$294K – 449
2024
Q4 		$294K Buy
5,553
+457
+9% +$25.6K 0.02% 619
2024
Q3 		$320K Sell
5,096
-982
-16% -$57.3K 0.02% 580
2024
Q2 		$359K Buy
6,078
+870
+17% +$54.4K 0.02% 522
2024
Q1 		$415K Sell
5,208
-893
-15% -$68.2K 0.03% 481
2023
Q4 		$482K Sell
6,101
-2,264
-27% -$161K 0.03% 450
2023
Q3 		$584K Buy
8,365
+449
+6% +$31.8K 0.05% 382
2023
Q2 		$547K Sell
7,916
-1,774
-18% -$126K 0.04% 414
2023
Q1 		$720K Sell
9,690
-451
-4% -$37.8K 0.06% 348
2022
Q4 		$945K Sell
10,141
-302
-3% -$29.1K 0.08% 266
2022
Q3 		$996K Buy
10,443
+46
+0.4% +$4.55K 0.09% 214
2022
Q2 		$963K Sell
10,397
-380
-4% -$37.1K 0.08% 245
2022
Q1 		$1.09M Sell
10,777
-2,224
-17% -$234K 0.08% 247
2021
Q4 		$1.34M Buy
13,001
+452
+4% +$41.8K 0.08% 254
2021
Q3 		$1.06M Buy
12,549
+1,618
+15% +$136K 0.07% 294
2021
Q2 		$912K Sell
10,931
-385
-3% -$31.5K 0.06% 319
2021
Q1 		$851K Sell
11,316
-5,785
-34% -$421K 0.06% 304
2020
Q4 		$1.17M Buy
17,101
+1,219
+8% +$79.3K 0.09% 201
2020
Q3 		$927K Buy
15,882
+1,607
+11% +$100K 0.08% 209
2020
Q2 		$927K Buy
14,275
+2,333
+20% +$147K 0.09% 178
2020
Q1 		$709K Buy
11,942
+5,682
+91% +$379K 0.08% 200
2019
Q4 		$465K Buy
6,260
+4,729
+309% +$332K 0.05% 305
2019
Q3 		$97K Sell
1,531
-7,381
-83% -$437K 0.02% 454
2019
Q2 		$486K Buy
8,912
+47
+0.5% +$2.53K 0.05% 268
2019
Q1 		$477K Buy
8,865
+1,319
+17% +$81.4K 0.05% 274
2018
Q4 		$494K Buy
7,546
+4,274
+131% +$319K 0.06% 247
2018
Q3 		$258K Buy
+3,272
New +$234K 0.07% 230

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Concourse Financial Group Securities's CVS Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of CVS Health (CVS) in Q1 2025, closing a stake of 5,553 shares — an estimated $294K sold.

Concourse Financial Group Securities first reported a position in CVS in Q3 2018 and held it in 26 quarters. The position peaked at $1.34M in Q4 2021. 1,753 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 5,553 CVS Health shares in Q1 2025, an estimated $294K.
  • Concourse Financial Group Securities first reported a position in CVS Health in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's CVS Health position peaked at $1.34M in Q4 2021.
  • 1,753 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.